Navidea生物制药(NAVB)

1.71 -0.08 -4.4693%

今开:1.49昨收:1.79
最高:1.74 最低:1.49
涨停价:0.0跌停价:0.0
总市值:4.9633455E7

Navidea生物制药的热门评论

Navidea生物制药(NAVB)05-14 04:12

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-012043 Act: 34 Size: 5 MB 网页链接查看全文

Navidea生物制药(NAVB)05-14 04:45

$Navidea生物制药(NAVB)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-21-012089 Act: 33 Size: 391 KB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:42

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-011697 Act: 34 Size: 100 KB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:18

$Navidea生物制药(NAVB)$ 8-K Current report, item 5.02 Accession Number: 0001437749-21-011698 Act: 34 Size: 20 KB 网页链接查看全文

Navidea生物制药(NAVB)2020-09-03 05:06

$Navidea生物制药(NAVB)$ 8-K Current report, items 1.01, 5.03, and 9.01 Accession Number: 0001437749-20-019237 Act: 34 Size: 448 KB 网页链接查看全文

兔斯基不吃面2020-05-22 20:26

$Navidea生物制药(NAVB)$ 下一个轮到ABUS生物制药哈哈哈,异曲同工查看全文

Navidea生物制药(NAVB)2020-01-31 23:27

【异动】$Navidea生物制药(NAVB)$ 23:27跌幅达-4.13%,现价1.16美元查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Navidea生物制药的最新评论

Navidea生物制药(NAVB)06-15 23:51

$Navidea生物制药(NAVB)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-21-081310 Act: 34 Size: 54 KB 网页链接查看全文

Navidea生物制药(NAVB)05-25 18:06

$Navidea生物制药(NAVB)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-21-002085 Act: 33 Size: 1 KB 网页链接查看全文

Navidea生物制药(NAVB)05-14 04:45

$Navidea生物制药(NAVB)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001437749-21-012089 Act: 33 Size: 391 KB 网页链接查看全文

Navidea生物制药(NAVB)05-14 04:12

$Navidea生物制药(NAVB)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-012043 Act: 34 Size: 5 MB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:42

$Navidea生物制药(NAVB)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-21-011697 Act: 34 Size: 100 KB 网页链接查看全文

Navidea生物制药(NAVB)05-12 04:18

$Navidea生物制药(NAVB)$ 8-K Current report, item 5.02 Accession Number: 0001437749-21-011698 Act: 34 Size: 20 KB 网页链接查看全文

Navidea生物制药(NAVB)05-07 06:45

$Navidea生物制药(NAVB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-21-011198 Size: 6 KB 网页链接查看全文

Navidea生物制药(NAVB)05-07 06:42

$Navidea生物制药(NAVB)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001437749-21-011196 Size: 2 KB 网页链接查看全文

Navidea生物制药(NAVB)05-06 05:27

$Navidea生物制药(NAVB)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001437749-21-010937 Act: 34 Size: 37 KB 网页链接查看全文

Navidea生物制药(NAVB)04-27 07:33

$Navidea生物制药(NAVB)$ 内部交易: 2021-04-23,Director,Witter Malcolm G ,买入,10000普通股, $1.60查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Navidea生物制药的公告

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ DEF 14A - Other definitive proxy statements Filed: 2016-07-01 AccNo: 0001144204-16-111082 Size: 564 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-06-28 AccNo: 0001299265-16-000008 Size: 136 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-06-29 AccNo: 0001144204-16-110558 Size: 64 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ PRE 14A - Other preliminary proxy statements Filed: 2016-06-15 AccNo: 0001144204-16-108339 Size: 594 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-06-02 AccNo: 0001144204-16-106529 Size: 18 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ SD - Filed: 2016-05-31 AccNo: 0001144204-16-105868 Size: 12 KB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-24 AccNo: 0001144204-16-104550 Size: 19 KBItem 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-17 AccNo: 0001144204-16-103083 Size: 134 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-16 AccNo: 0001564590-16-019588 Size: 5 MB 网页链接

$NAVIDEA BIOPHARMACEUTICALS I(NAVB)$ 8-K - Current report Filed: 2016-05-13 AccNo: 0001144204-16-101918 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32